Immune Responses in Patients Treated With Raltegravir (RAG-1/2)
This study has been withdrawn prior to enrollment.
(Unexpected and severe difficulties in recruitment.)
McGill University Health Center
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Chris Tsoukas, McGill University Health Center
First received: November 4, 2008
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||August 2011|
|Primary Completion Date:||August 2011 (Final data collection date for primary outcome measure)|